CatalystWireBeta

ECO Animal Health Group (EAH): Profit upgrade

This situation live

EAH ECO Animal Health Group

£64m · 95.5p · +2% since the first step
114.0p 81.0p Now 95.5p · 23 Oct +5% −14% +8% Nov ’25DecJan ’26FebMarAprMayJunJulAugSepOct
Upgrade / downgrade cycle
Profit upgrade
guidance raised · third in 12 months
Directionahead of expectations / raised
Reaction on the day+3%
In 12 months3 statements in the same direction
Company's wordsWe were delighted to receive EU marketing authorisation for our first vaccine, ECOVAXXIN® MS in December 2025, marking our commercial entry into the preventatives medicine space. ↗

As of 15 Jul 2026 ↗

Since Oct 2023: 1145 situations of this kind; median share price +0% six months after they opened

Every step · 3
  1. 1 Dec 2025 guidance raised · +4% on the day – Post-period end, we achieved an important milestone in our R&D pipeline through the receipt of a Positive Opinion from the European Medicines Agency for... ↗
  2. 19 Mar 2026 guidance raised · +6% on the day – Revenue growth has been particularly strong in North America and Latin America, despite currency headwinds and tariff challenges. ↗
  3. 15 Jul 2026 guidance raised · third in 12 months – We were delighted to receive EU marketing authorisation for our first vaccine, ECOVAXXIN® MS in December 2025, marking our commercial entry into the... ↗

What is happening

ECO Animal Health Group: Profit upgrade – guidance raised · third in 12 months. ['guidance raised · third in 12 months']

In short
ECO Animal Health Group raised its guidance on 15 Jul 2026; the shares moved +3% on the day. It is the third such statement in 12 months.
Announced
1 Dec 2025 · guidance raised · +4% on the day
Latest
15 Jul 2026 · guidance raised · +3% on the day
Briefing Pro

New to ECO Animal Health Group? Get up to speed in 2 minutes.

What it does, how it got here, what management promised and delivered – written from its own announcements.

Get the EAH briefing →
Ask EAH Beta
Ask anything about ECO Animal Health Group

Answered from its own announcements and reported figures, every statement linked to its source.

From the company's own announcements. Not investment advice.

Also at ECO Animal Health Group 1 open
Project milestonesECOVAXXIN MS EU approval and launch – USDA-CVB accepted field safety data; US licence pending Insider conviction1 director buying – £20k in 1 buy · closed Insider conviction1 director buying – £20k in 1 buy · closed Insider conviction1 director buying – £40k in 2 buys · closed Upgrade / downgrade cycleProfit upgrade – guidance raised · closed ECO Animal Health Group – company page →

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note